Myeloma Minute
November 8, 2012
|
|
|
11.08.12 |
 |  |  |  | | November 8, 2012 |  |  |  |  |  |  | | | | |  | | Overcoming Genetic Transformation in Multiple Myeloma |  | | Dr. Kenneth Anderson reviews the myeloma landscape at 2012 at the Annual NCCN Congress According to IMF Chairman and Co-founder Brian G.M. Durie, a key aspect is the recommendation for use of a 3-drug combination (triplet) early to achieve disease control and reduce the chance of new genetic mutations. Dr. Anderson supports the use of lenalidomide maintenance post-autologous transplantation despite some increased risk of second primary malignancies (SPMs). He emphasizes the need to avoid oral melphalan use, which does enhance the SPM risk. READ MORE | |
| | Advocacy Update: The Healthcare Landscape in the Aftermath of the 2012 Elections |  |
| With the end of the election season, the IMF is moving forward with its work to ensure that key provisions of health reform that provide high quality of care for cancer patients are maintained. We will continue to educate legislators at the state and federal level about the needs of cancer patients, and, working with our coalition of cancer organizations, we will continue to provide input in Washington as they determine policies and regulations. READ MORE | |
| | Atlanta-Area IMF Support Group Members Become Super Advocates by Reaching Out to Friends, Family, Co-Workers |  |
| This month the IMF honors all members of the Atlanta Area Support Groups as our Advocates of the Month for November 2012 for their contribution to our Postcards for Parity program. Gail McCray, co-support group leader for the Southside Atlanta area, got the ball rolling by distributing postcards and encouraging members to educate friends, families, and co-workers about the disparity of health care coverage for oral and IV treatments. The response was terrific: more than 400 postcards have been sent to Georgia legislators! READ MORE | |
| | Support Group Leaders Wear Their Big Hearts and Hometown Pride on Their Sleeves |  |
| My life was deeply touched this fall by three special, hardworking couples: Karl and Lorraine Vollstedt, Howard and Teresa Martinson, and Harold and Sue VanDuyn. Each went out of their way to welcome me into their local myeloma support group community. READ MORE | | | | | | | | Join Our Mailing List |
| | | | | |
|
=
|
 related videos  related articles |
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
10 PASSI PER CURA MIGLIORE®
10 Steps to Better Care®
10 Steps to Stress Control – From Fear to Hope
10 Steps to Happy Holidays
2011 IMF Holiday Gift Boutique
New Study: The Search for Criteria to Diagnose Active Myeloma at an Early Stage
Comprender El Tratamiento con Dosis Altas con Rescate de Células Madre
Advocacy Update - April 2013
Advocacy Update - March 2013
Advocacy Update - September 2012
Advocacy Update: The Healthcare Landscape in the Aftermath of the 2012 Elections
As the Bill Turns...Episode 3
ASCO 2012: Dr. Pashos - Race- and health-related quality of life among patients newly diagnosed with multiple myeloma
Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference
Breaking News: Pomalyst® (pomalidomide) Approved by the FDA for Relapsed Myeloma
FDA Recognition of Extended Survival with VELCADE® Indicates Important New Progress in Treating the Disease
IMF 6th Annual Comedy Celebration
benefiting the Peter Boyle Research Fund
October 27, 2012
IMF Board Member Edith Mitchell, M.D., FACP, Named 2012 Recipient Of ASCO Humanitarian Award
IMF Nurse Leadership Board (NLB) White Paper on Subcutaneous Velcade® (bortezomib)
IMF Responds to Proposed Changes in CMS PET Scan Policy
It is Officially Myeloma Awareness Month Across the Country!
Live from ASH 2012: Journalists’ Workshop with Leading Myeloma Experts
Live! The Boca Raton Patient & Family Seminar
Living Well with Myeloma Teleconference Series:
How to Prevent Infection in Myeloma Patients
Myelom Merkur - Frühjahr 2012 - #901
MYELOMA AWARENESS MONTH 2012 FACT-A-DAY
Myeloma Canada Announces Recipient of this Year’s Research Grant
Myeloma Minute
April 11, 2013
Myeloma Minute
April 18, 2013
Myeloma Minute
April 26, 2012
Myeloma Minute
February 7, 2013
Myeloma Minute
January 31, 2013
Myeloma Minute
July 26, 2012
Myeloma Minute
June 28, 2012
Myeloma Minute
March 7, 2013
Myeloma Minute
May 17, 2012
Myeloma Minute
October 25, 2012
Myeloma Minute
May 24, 2012
Myeloma Today Spring 2013
New! Free Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
Pomalidomide + carfilzomib trial recruiting patients.
Should Myeloma Patients Get a Flu Shot? If So, Which One?
Special Myeloma Minute on FDA Approved Data for VELCADE®, including long-term survival data
STEP 7: CONSOLIDATION AND MAINTENANCE - ARE THEY NEEDED? REFERENCES
STEP 8: KEEPING TRACK OF THE MYELOMA - MONITORING WITHOUT MYSTERY
Stillwater, Minn., Myeloma Support Group Marks "Centennial" Anniversary
Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
The Emerging Role of Kyprolis in the Treatment Paradigm
The IMF Spearheads New Coalition’s First Meeting on State Health Exchanges
The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
UPCOMING WEBCAST OF THE IMWG CONFERENCE SERIES "MAKING SENSE OF TREATMENT"
Wednesday, June 12, 2013 in Stockhom, Sweden
Клиническое значение электрофореза белковых фракций
back
print